Inflammation is associated with high disease burden and adverse outcomes in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a real-world evidence study
Atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD) often coexist, worsening patient prognosis. Inflammation, commonly assessed by C-reactive protein (CRP), is a potential therapeutic target. Trials of inflammation-targeted therapies highlight the need for evidence on the clinical impa...